SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 IN A DOSE ESCALATING REGIMEN IN PATIENTS WITH METASTATIC RENAL-CELL ADENOCARCINOMA

被引：0
|
作者：
WHITEHEAD, RP
WARD, D
HEMINGWAY, L
HEMSTREET, GP
BRADLEY, E
KONRAD, M
机构：
[1] UNIV OKLAHOMA,HLTH SCI CTR,DEPT MED,OKLAHOMA CITY,OK 73190
[2] UNIV OKLAHOMA,HLTH SCI CTR,DEPT UROL,OKLAHOMA CITY,OK 73190
[3] CETUS CORP,EMERYVILLE,CA 94608
来源：
CANCER RESEARCH | 1990年 / 50卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6708 / 6715
页数：8
相关论文
共 50 条
  • [41] A RANDOMIZED STUDY OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY VERSUS INTERLEUKIN-2 PLUS INTERFERON-ALPHA AS FIRST LINE THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    LISSONI, P
    BARNI, S
    ARDIZZOIA, A
    ANDRES, M
    SCARDINO, E
    CARDELLINI, P
    DELLABITTA, R
    TANCINI, G
    TUMORI, 1993, 79 (06) : 397 - 400
  • [42] PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH RECOMBINANT INTERLEUKIN-2
    PALMER, PA
    VINKE, J
    PHILIP, T
    NEGRIER, S
    ATZOPODIEN, J
    KIRCHNER, H
    OSKAM, R
    FRANKS, CR
    ANNALS OF ONCOLOGY, 1992, 3 (06) : 475 - 480
  • [43] REVERSIBLE NEUROTOXICITY DURING INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    VANLAAR, JM
    VANBUCHEM, MA
    WEYL, N
    CLETON, FJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) : 1895 - 1897
  • [44] TREATMENT OF 283 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CANCER USING HIGH-DOSE BOLUS INTERLEUKIN-2
    ROSENBERG, SA
    YANG, JC
    TOPALIAN, SL
    SCHWARTZENTRUBER, DJ
    WEBER, JS
    PARKINSON, DR
    SEIPP, CA
    EINHORN, JH
    WHITE, DE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (12): : 907 - 913
  • [45] INTERLEUKIN-2 AND INTERFERON IN RENAL-CELL CARCINOMA
    WERSALL, P
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (1-2): : 71 - 76
  • [46] MYOSITIS ASSOCIATED WITH INTERLEUKIN-2 THERAPY IN A PATIENT WITH METASTATIC RENAL-CELL CARCINOMA
    ESTEVALORENZO, F
    JANIK, JE
    FENTON, RG
    EMSLIESMITH, A
    ENGEL, AG
    LONGO, DL
    CANCER, 1995, 76 (07) : 1219 - 1223
  • [47] CARDIOPULMONARY TOXICITY OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 IN 199 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CARCINOMA
    WHITE, RL
    SCHWARTZENTRUBER, DJ
    GULERIA, A
    MACFARLANE, MP
    WHITE, DE
    TUCKER, E
    ROSENBERG, SA
    CANCER, 1994, 74 (12) : 3212 - 3222
  • [48] COMBINATION OF INTERLEUKIN-2 AND GAMMA-INTERFERON IN METASTATIC RENAL-CELL CARCINOMA
    ESCUDIER, B
    FARACE, F
    ANGEVIN, E
    TRIEBEL, F
    ANTOUN, S
    LECLERCQ, B
    BRANDELY, M
    ABOUDARAM, A
    NITENBERG, G
    HERCEND, T
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 724 - 728
  • [49] RENAL-CELL CARCINOMA AND INTERLEUKIN-2 - A REVIEW
    WAGSTAFF, J
    BAARS, JW
    WOLBINK, GJ
    HOEKMAN, K
    EERENBERGBELMER, AJM
    HACK, CE
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (03) : 401 - 408
  • [50] Subcutaneous interleukin-2 and interferon in the treatment of patients with metastatic renal cell carcinoma -: Less efficacy compared with intravenous interleukin-2 and interferon α
    Ravaud, A
    Delva, R
    Gomez, F
    Chevreau, C
    Douillard, JY
    Peny, J
    Coudert, B
    Négrier, S
    CANCER, 2002, 95 (11) : 2324 - 2330
12345